Janus Henderson Group PLC Ascendis Pharma A/S Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,918,813 shares of ASND stock, worth $593 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
3,918,813
Previous 3,767,203
4.02%
Holding current value
$593 Million
Previous $569 Million
6.15%
% of portfolio
0.29%
Previous 0.32%
Shares
21 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.53 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$751 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$650 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$635 Million7.81% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$395 Million0.06% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.44B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...